A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : FS / Fanconi syndrome

[Related PubMed/MEDLINE]
Total Number of Papers: 58
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   FS  (>> Co-occurring Abbreviation)
Long Form:   Fanconi syndrome
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2018 Acquired Fanconi syndrome secondary to light chain deposition disease associated with monoclonal gammopathy of renal significance: A case report. MGRS, TBMs
2018 Acute Lymphoblastic Leukemia Presenting as Fanconi Syndrome. ALL
2018 Impact of atypical mitochondrial cyclic-AMP level in nephropathic cystinosis. ciPTEC, NC
2018 Incidence of renal Fanconi syndrome in patients taking antiretroviral therapy including tenofovir disoproxil fumarate. TDF
2017 Current anti-myeloma therapies in renal manifestations of monoclonal light chain-associated Fanconi syndrome: a retrospective series of 49 patients. eGFR, FLC, HDM, LC
2017 Growth hormone therapy for a patient with idiopathic Fanconi syndrome and growth hormone deficiency. GHD, rhGH
2016 Acquired Fanconi syndrome in four cats treated with chlorambucil. ---
2016 Dental findings in Brazilian patients with Fanconi syndrome. ---
2016 Fanconi Syndrome and Antiretrovirals: It Is Never Too Late. ART
10  2016 Fanconi syndrome due to light chain proximal tubulopathy in a patient with multiple myeloma. LCPT
11  2015 A pharmacogenetic candidate gene study of tenofovir-associated Fanconi syndrome. ABC, AK2, SNP, TDF, TDF-FS
12  2015 A single-center case series of eight patients with the rare plasma cell dyscrasia of acquired Fanconi syndrome secondary to monoclonal gammopathy. ESRD, MGUS, MM, PUMCH
13  2015 Hypokalemic paralysis secondary to tenofovir induced fanconi syndrome. ---
14  2015 Light chain proximal tubulopathy with cast nephropathy in a case of multiple myeloma. CN, LCPT
15  2015 Transfusion-dependent thalassaemic patients with renal Fanconi syndrome due to deferasirox use. NTUH
16  2014 A case of Fanconi syndrome accompanied by crystal depositions in tubular cells in a patient with multiple myeloma. ---
17  2014 An uncommon presentation of Sjogren's syndrome and brucellosis. DIC, NDI, RTA, SS
18  2014 Drug-induced renal Fanconi syndrome. PT
19  2014 Fanconi syndrome accompanied by renal function decline with tenofovir disoproxil fumarate: a prospective, case-control study of predictors and resolution in HIV-infected patients. CrCl, TDF
20  2014 Fanconi syndrome caused by low-dose adefovir dipivoxil. ADV
21  2014 Tenofovir induced Fanconi syndrome: A rare cause of hypokalemic paralysis. ---
22  2014 Urine retinol-binding protein 4: a functional biomarker of the proximal renal tubule. ---
23  2012 Analysis of molecular forms of urine Retinol-Binding Protein in Fanconi Syndrome and design of an accurate immunoassay. MS
24  2012 Fanconi syndrome and chronic kidney disease in paroxysmal nocturnal hemoglobinuria: effect of eculizumab therapy. CKD, PNH
25  2012 Specific impairment of proximal tubular cell proliferation by a monoclonal kappa light chain responsible for Fanconi syndrome. LC, PTCs
26  2011 Novel techniques and newer markers for the evaluation of "proximal tubular dysfunction". ---
27  2011 Toward understanding renal Fanconi syndrome: step by step advances through experimental models. Ig, LC
28  2010 Fanconi syndrome in lymphoma patients: report of the first case series. ATLL, HTLV1
29  2010 Hypokalemic paralysis as primary presentation of Fanconi syndrome associated with Sjogren syndrome. SS
30  2009 Urinary proteome pattern in children with renal Fanconi syndrome. CE-MS
31  2008 Aristolochic acid nephropathy due to herbal drug intake manifested differently as Fanconi's syndrome and end-stage renal failure--a 7-year follow-up. AA, AAN, ESRF
32  2008 Lysosomal enzymuria is a feature of hereditary Fanconi syndrome and is related to elevated CI-mannose-6-P-receptor excretion. CI-MPR, LDH, M6P, NAG
33  2007 Efforts to establish an animal model of Fanconi syndrome after ifosfamide administration to rats. IFO
34  2007 Patient with Fanconi Syndrome (FS) and retinitis pigmentosa (RP) caused by a deletion and duplication of mitochondrial DNA (mtDNA). mtDNA, RP
35  2006 Abacavir-induced reversible Fanconi syndrome with nephrogenic diabetes insipidus in a patient with acquired immunodeficiency syndrome. HIV, NDI
36  2006 Acquired Fanconi's syndrome associated with tenofovir therapy. ---
37  2006 Role of the monoclonal kappa chain V domain and reversibility of renal damage in a transgenic model of acquired Fanconi syndrome. ---
38  2005 Comparison of growth in primary Fanconi syndrome and proximal renal tubular acidosis. pRTA, SDS
39  2005 Exfoliated human proximal tubular cells: a model of cystinosis and Fanconi syndrome. PTC
40  2005 Fanconi's syndrome induced by a monoclonal Vkappa3 light chain in Waldenstrom's macroglobulinemia. LC
41  2005 The ultrastructural basis of renal pathology in monoclonal gammopathies. AL, EM, G-LCs, GN, Igs, IT, LC, MG, MIDD, PCR, T-LCs, THP
42  2004 Acquired Fanconi syndrome is an indolent disorder in the absence of overt multiple myeloma. ESRD, MGUS, MM, SMM
43  2004 Melatonin attenuates ifosfamide-induced Fanconi syndrome in rats. IFO
44  2004 The urinary proteome in Fanconi syndrome implies specificity in the reabsorption of proteins by renal proximal tubule cells. ---
45  2003 Drug-induced Fanconi's syndrome. ---
46  2000 Adult Fanconi syndrome secondary to light chain gammopathy. Clinicopathologic heterogeneity and unusual features in 11 patients. MGUS
47  2000 [The clinical and biochemical manifestations of Fanconi syndrome: a report of 42 cases]. ---
48  1999 Deletions in the mitochondrial DNA and decrease in the oxidative phosphorylation activity of children with Fanconi syndrome secondary to antiblastic therapy. CARBO, IFO, mtDNA, NAD, OXPHOS
49  1999 L-Histidinol attenuates Fanconi syndrome induced by ifosfamide in rats. IFO, LHL
50  1999 Mutational analysis in murine models for myeloma-associated Fanconi's syndrome or cast myeloma nephropathy. LC
51  1999 Thymoquinone attenuates ifosfamide-induced Fanconi syndrome in rats and enhances its antitumor activity in mice. EAC, IFO, TQ
52  1998 Taurine attenuates fanconi syndrome induced by ifosfamide without compromising its antitumor activity. EAC, IFO, Tau
53  1996 Glycine attenuates Fanconi syndrome induced by maleate or ifosfamide in rats. Crn, Gly, GSH, IFO, MAL, PT
54  1989 Renal Fanconi syndrome: developmental basis for a new animal model with relevance to human disease. BBMV, SA
55  1987 Effect of bicarbonate and phosphate on renal phosphate leak in experimental Fanconi syndrome. ---
56  1984 Renal refractoriness to PTH in experimental Fanconi syndrome: evidence for intact adenylate cyclase activation. AC, PTH
57  1983 Hypercalciuria in a child with primary Fanconi syndrome and hearing loss. ---
58  1972 Renal tubular acidosis in infants: the several kinds, including bicarbonate-wasting, classic renal tubular acidosis. RBW, RTA